TARS - CIK 0001819790
Tarsus Pharmaceuticals, Inc. has filed 617 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (278 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SEC STAFF LETTER | - | 2020-10-14 | - |
| Company correspondence | CORRESP | 2020-10-13 | - |
| Company correspondence | CORRESP | 2020-10-13 | - |
| 8-A12B | - | 2020-10-13 | - |
| Company correspondence | CORRESP | 2020-10-09 | - |
| S-1/A | - | 2020-10-09 | - |
| SEC correspondence | UPLOAD | 2020-10-07 | - |
| Company correspondence | CORRESP | 2020-10-06 | - |
| Company correspondence | CORRESP | 2020-09-25 | - |
| IPO registration | S-1 | 2020-09-25 | - |
| SEC correspondence | UPLOAD | 2020-09-24 | - |
| DRSLTR | - | 2020-09-14 | - |
| DRS/A | - | 2020-09-14 | - |
| SEC STAFF LETTER | - | 2020-09-04 | - |
| SEC correspondence | UPLOAD | 2020-09-04 | - |
| DRS/A | - | 2020-08-14 | - |
| DRS | - | 2020-08-07 | - |